Trybulski E J, Kramss R H, Mangano R M, Rusinko A
American Cyanamid Company, Lederle Laboratories, Pearl River, New York 10965.
J Med Chem. 1990 Dec;33(12):3190-8. doi: 10.1021/jm00174a015.
A series of optically pure 2-[substituted-3-aminopropynyl]pyrrolidine derivatives, which are restricted-rotation analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5, compound 1), have been prepared from d- and l-proline. The compounds when tested in a series of in vitro muscarinic assays [[3H]CD (cortex), [3H]QNB (cortex), [3H]PZ (cortex), [3H]QNB (heart), [3H]QNB + GppNHp (heart)] were found to have weaker muscarinic properties than compound 1. The decrease in affinity was attributed to the increased size of the molecule resulting from the addition of a methylene group to form the pyrrolidine ring. The use of optically active compounds provided a more detailed examination of the complex pharmacological effects of the flexible muscarinic agent 1. The R enantiomers in the acetamide derivatives 12b, 12d, and 12f had a 5-10-fold greater affinity for the muscarinic receptor than the corresponding S enantiomers. A 5-fold difference or less found in the (R)- and (S)-carbamate derivatives 9, 15, and 16 suggested close overlap of the two enantiomers in the receptor binding domain. The affinity differences found in the enantiomeric acetamido derivatives when compared to those of the carbamate analogues may be the result of limited rotation of the acetamido group.
一系列光学纯的2-[取代-3-氨基丙炔基]吡咯烷衍生物,它们是毒蕈碱剂N-甲基-N-(1-甲基-4-吡咯烷基-2-丁炔基)乙酰胺(BM-5,化合物1)的限制旋转类似物,已由d-和l-脯氨酸制备而成。在一系列体外毒蕈碱测定中([³H]CD(皮质)、[³H]QNB(皮质)、[³H]PZ(皮质)、[³H]QNB(心脏)、[³H]QNB + GppNHp(心脏))对这些化合物进行测试时,发现它们的毒蕈碱特性比化合物1弱。亲和力的降低归因于分子因添加亚甲基形成吡咯烷环而增大。使用光学活性化合物对柔性毒蕈碱剂1的复杂药理作用进行了更详细的研究。乙酰胺衍生物12b、12d和12f中的R对映体对毒蕈碱受体的亲和力比相应的S对映体高5至10倍。在(R)-和(S)-氨基甲酸酯衍生物9、15和16中发现的5倍或更小的差异表明两种对映体在受体结合域中紧密重叠。与氨基甲酸酯类似物相比,在对映体乙酰胺衍生物中发现的亲和力差异可能是乙酰胺基团旋转受限的结果。